CD36 and posterior cortical atrophy: Evidence derived from prostate cancerous tissue and patient-derived xenograft mouse models suggest that CD36 blockades and subsequent inhibition of the mediated fatty acid uptake may provide a beneficial effect in a preclinical PCa setting and pave the way for the exploration of potential novel therapeutic strategies [67].